Literature DB >> 15134485

Drug delivery systems for brain tumor therapy.

Jarkko Rautioa1, Prashant J Chikhale.   

Abstract

Brain tumors are one of the most lethal forms of cancer. They are extremely difficult to treat. Although, the rate of brain tumor incidence is relatively low, the field clearly lacks therapeutic strategies capable of overcoming barriers for effective delivery of drugs to brain tumors. Clinical failure of many potentially effective therapeutics for the treatment of brain tumors is usually not due to a lack of drug potency, but rather can be attributed to shortcomings in the methods by which a drug is delivered to the brain and into brain tumors. In response to the lack of efficacy of conventional drug delivery methods, extensive efforts have been made to develop novel strategies to overcome the obstacles for brain tumor drug delivery. The challenge is to design therapeutic strategies that deliver drugs to brain tumors in a safe and effective manner. This review provides some insight into several potential techniques that have been developed to improve drug delivery to brain tumors, and it should be helpful to clinicians and research scientists as well.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134485     DOI: 10.2174/1381612043384916

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.

Authors:  Silke Glage; Andrew L Lewis; Patricia Mertens; Steffen Baltes; Peter Geigle; Thomas Brinker
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

Review 2.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 3.  Transendothelial Transport and Its Role in Therapeutics.

Authors:  Ravi Kant Upadhyay
Journal:  Int Sch Res Notices       Date:  2014-08-27

4.  Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model.

Authors:  Gustavo Pradilla; Paul P Wang; Patrik Gabikian; Khan Li; Carolyn A Magee; Kevin A Walter; Henry Brem
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

5.  Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment.

Authors:  Pin-Yuan Chen; Hao-Li Liu; Mu-Yi Hua; Hung-Wei Yang; Chiung-Yin Huang; Po-Chun Chu; Lee-Ang Lyu; I-Chou Tseng; Li-Ying Feng; Hong-Chieh Tsai; Shu-Mei Chen; Yu-Jen Lu; Jiun-Jie Wang; Tzu-Chen Yen; Yunn-Hwa Ma; Tony Wu; Jyh-Ping Chen; Jih-Ing Chuang; Jyh-Wei Shin; Chuen Hsueh; Kuo-Chen Wei
Journal:  Neuro Oncol       Date:  2010-07-27       Impact factor: 12.300

6.  Epirubicin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers.

Authors:  Violette Renard Recinos; Kimon Bekelis; Shira G Ziegler; Ditty Vick; Samuel Hertig; Betty M Tyler; Khan W Li; Thomas Kosztowski; Federico G Legnani; Henry Brem; Alessandro Olivi
Journal:  J Neurooncol       Date:  2009-08-20       Impact factor: 4.130

7.  Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.

Authors:  Beata Chertok; Allan E David; Yongzhuo Huang; Victor C Yang
Journal:  J Control Release       Date:  2007-06-02       Impact factor: 9.776

Review 8.  Carbon Dots: An Innovative Tool for Drug Delivery in Brain Tumors.

Authors:  Giovanna Calabrese; Giovanna De Luca; Giuseppe Nocito; Maria Giovanna Rizzo; Sofia Paola Lombardo; Giulia Chisari; Stefano Forte; Emanuele Luigi Sciuto; Sabrina Conoci
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

9.  Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors.

Authors:  Divya Khaitan; Nagendra S Ningaraj
Journal:  Front Pharmacol       Date:  2013-05-29       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.